Suven gets establishment inspection report from USFDA
Suven Life Sciences has received the Establishment Inspection Report (EIR) from the US health regulator for its manufacturing plant near Hyderabad. Suven Life Sciences Ltd has undergone USFDA rene... SUVENS Pashamylarams Unit Successfully completes US FDA Inspection
Suven Life Sciences Ltd has informed BSE regarding a Press Release dated July 21, 2016 titled "SUVENS Pashamylarams Unit Successfully completes US FDA Inspection". Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended June 30, 2016
Suven Life Sciences Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended June 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Shareholding for the Period Ended June 30, 2016
Suven Life Sciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2016. For more details, kindly Click here AGM on August 10, 2016
Suven Life Sciences Ltd has informed BSE that the 27th Annual General Meeting (AGM) of the Company will be held on August 10, 2016. Suven gets 2 product patents; shares surge nearly 2%
Suven Life Sciences has been granted a patent each by India and South Africa for a drug used in the treatment of neuro-degenerative diseases. In a BSE filing today, Suven Life said it has been gran... Suven Life Sciences secures two (2) Product Patents in India and South Africa
Suven Life Sciences Ltd has informed BSE regarding a Press Release dated July 12, 2016 titled "Suven Life Sciences secures two (2) Product Patents in India and South Africa". Suven Life Sciences gets patent for neuro-degenerative drug
In a BSE filing today, it said it has been granted "one product patent from Europe and two patents from Eurasia corresponding to New Chemical Entities. Suven Life Sciences secures three (3) Product Patents in Europe and Eurasia
Suven Life Sciences Ltd has informed BSE regarding a Press Release dated June 29, 2016 titled "Suven Life Sciences secures three (3) Product Patents in Europe and Eurasia". Suven gets product patents from Canada, Hong Kong
Patents are for new chemical entities, for treating disorders associated with neurodegenerative diseases